Clinical associations and genetic interactions of oncogenic BRAF alleles
BRAF is a serine/threonine-specific protein kinase that regulates the MAPK/ERK signaling pathway, and mutations in the BRAF gene are considered oncogenic drivers in diverse types of cancer. Based on the signaling mechanism, oncogenic BRAF mutations can be assigned to three different classes: class 1...
Main Author: | Sebastian A. Wagner |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2022-10-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/14126.pdf |
Similar Items
-
Metastatic BRAF V600E-Mutated Thyroid Carcinoma: Molecular/Genetic Profiling Brings a New Therapeutic Option
by: Joana S. Reis, et al.
Published: (2022-11-01) -
Oncogenic BRAF Alterations and Their Role in Brain Tumors
by: Felix Behling, et al.
Published: (2019-06-01) -
Oncogenic BRAF-Mediated Melanoma Cell Invasion
by: Hezhe Lu, et al.
Published: (2016-05-01) -
BRAF: A Two-Faced Janus
by: Pasquale Pisapia, et al.
Published: (2020-11-01) -
V-raf murine sarcoma viral oncogene homolog B (BRAF) mutations in hairy cell leukaemia
by: Neeraj Arora, et al.
Published: (2015-01-01)